Showing 2640 results
- Key Release /Ad hoc announcement pursuant to Art. 53 LR FDA also approved complementary diagnostic imaging agent, Locametz®, after radiolabeling with gallium-68 for the identification of PSMA-positive…
- Statement /
- Media Release /CHMP opinion based on Phase III REACH2 and REACH3 trials that showed Jakavi improved response rates and failure-free survival compared to best available therapy1,2 Graft-versus-host disease (GvHD)…
- Media Release /Positive opinion paves way for third indication in Europe for Kymriah, a potentially definitive single infusion CAR-T cell therapy treatment optionCHMP opinion based on Phase II global ELARA trial…
- Media Library /
- Media Library /
- Media Library /
- Media Library /
- Featured News /
The RUXCOVID clinical trial highlights the Novartis commitment to leverage our expertise and resources to support the global response to the COVID-19 pandemic.
- Media Library /
Pagination
- ‹ Previous page
- 1
- …
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- …
- 264
- › Next page